This site uses cookies, so that our service can work better. I understand

David Erritzoe

Session:
Opening Lecture

Institute:
Neuropsychopharmacology Unit & Centre for Psychedelic Research, Department of Psychiatry, Imperial College London, London, the United Kingdom
 
Websites:

https://www.imperial.ac.uk/people/d.erritzoe

 
ResearchGate:

https://www.researchgate.net/profile/David_Erritzoe

Biography: 
Qualified as a medical doctor at Copenhagen University Medical School in 2001 and currently holds an Academic Clinical Lectureship in Psychiatry at Imperial College London. Alongside his clinical training in medicine/psychiatry, David has been involved in psychopharmacological research, using brain-imaging techniques such as PET and MRI. Initially working at Columbia University in New York, he then undertook a PhD at University Hospital Rigshospitalet in Copenhagen. Since 2009, under the mentorships of Profs Anne Lingford-Hughes and David Nutt at Imperial College London, he has conducted post-doc imaging research in the neurobiology of addictions and major depression. Together with Prof Nutt and Dr Carhart-Harris he is also investigating the neurobiology and therapeutic potential of MDMA and classic psychedelics.

Abstract:


TBA